Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
53.79
+1.46 (2.79%)
Jun 25, 2026, 4:00 PM EDT - Market closed
Scholar Rock Holding Market Cap
Scholar Rock Holding has a market cap or net worth of $6.45 billion as of June 26, 2026. Its market cap has increased by 97.23% in one year.
Market Cap
6.45B
Enterprise Value
6.17B
1-Year Change
97.23%
Ranking
Category
Stock Price
$53.79
Market Cap Chart
Since May 24, 2018, Scholar Rock Holding's market cap has increased from $378.83M to $6.45B, an increase of 1,601.45%. That is a compound annual growth rate of 41.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 6.45B | 43.44% |
| Dec 31, 2025 | 4.49B | 11.06% |
| Dec 31, 2024 | 4.05B | 198.32% |
| Dec 29, 2023 | 1.36B | 190.08% |
| Dec 30, 2022 | 467.55M | -46.39% |
| Dec 31, 2021 | 872.09M | -46.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.31B |
| Mirum Pharmaceuticals | 7.01B |
| PTC Therapeutics | 7.00B |
| Cogent Biosciences | 6.41B |
| Centessa Pharmaceuticals | 6.27B |
| CG Oncology | 6.06B |
| Belite Bio | 5.93B |
| Ligand Pharmaceuticals | 5.71B |